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induced foci which was in accordance with the progression of 
DNA repair and the declining dose rates. The absorbed dose 
in most patients treated with 131I exceeded 20mGy in the first 
hour, and in these patients, the on-set of a fast repair 
component was observed. 
Conclusions: With the experimental results and model 
calculations presented in this work, for the first time a dose-
response relationship and a description of the time course of 
the in-vitro and in-vivo damage response after internal 
irradiation of β−-emitters could be established. 
 
Keywords: gamma-H2AX and 53BP1, radionuclide therapy, 
dosimetry 
 
77 
A quantitative assessment of intra-fractional tumor motion 
and deformation error on planned dose at conventional 
proton therapy 
A. Ebrahimi1, A. E. Torshabi1 
1 Medical Radiation Division, Department of Electrical and 
Computer Engineering, Graduate University of Advanced 
Technology, Haftbagh St. 7631133131 Kerman, Iran 
  
Purpose: In proton therapy, two major beam delivery 
techniques are used which are referenced as active and 
passive delivery strategies. In latter case, an effective dose 
distribution into tumor volume is created by pencil beam 
extracted from the accelerator exit window. To do this aim, 
the modulation is performed to produce two uniform beam 
profiles: 1) along with beam trajectory and 2) in lateral 
direction vertical to beam direction. The first dose profile 
cover tumor volume in target depth against beam direction 
and the second lateral profile include tumor volume, 
transversely. Several passive devices are utilized to create 
depth dose profile known as Spread-Out Bragg Peak (SOBP) 
and transverse dose profiles. In proton therapy, the final 
purpose is to produce a three dimensional (3D) homogeneous 
dose distribution onto the tumor volume while minimizing the 
dose to the surrounding healthy tissues around the tumor. 
Relating to moving and deforming targets, the delivery dose 
is not matched with the planned dose. 
Methods: Our goal in this work is to obtain a quantitative 
assessment of three dimensional dose distribution on the 
moving and deforming targets and surrounding normal tissues 
affected by the breathing motion. For this aim, a simulation 
study was performed using Monte Carlo FLUKA code. The 
effect of each of the parameters in a clinical passive beam 
scanning system on radiotherapy dosage was considered. The 
dose deposition from protons was simulated for fields 
designed for the treatment of dynamic, deformed and static 
tumors. 
Results: Dose distribution results of Monte Carlo method 
simulation were compared with the results obtained during 
experimental process at Cyclotron and Radioisotope Center 
(CYRIC) in Tohoku University. Final analyzed results represent 
that the uniformity of dose distribution on all given tumors 
are up to 95% of uniformity that proves a successful dose 
delivery onto tumor as well according to planned dose. The 
results of dose distribution into tumor and surrounding 
healthy tissues around the tumor for static spherical case 
regarding with deformed tumors and moving tumors were 
obtained. Conclusion: In conventional proton therapy a 
significant dose is delivered to the normal tissues in 
comparison with stationary condition without getting any 
strategy to limit ITV region such as motion gated or real-time 
tumor tracking strategies. The accuracy of dose distribution 
increasing with decreasing magnitude of deformation, moving 
and stretching of the tumor. 
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An initial design of a compact, high current Fixed Field 
Alternating Gradient accelerator has been made for the 
direct production of 99mTc and the production of a number of 
therapeutic isotopes that currently available only in limited 
quantities or not at all. These studies indicate that the FFAG 
could in principle accelerate a proton beam of up to 20mA to 
at least 30 MeV and high current alpha beams to a similar 
energy. This presentation will describe the FFAG and show 
what radioisotope yields should be possible. It will also 
outline the next steps in the project. It should be noted that 
the same basic FFAG design is being extended to the energies 
required for cancer therapy with light ion beams.   
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